Steven Nichtberger, MD, is the Co-founder, Chairman, and CEO of Cabaletta Bio, a clinical-stage biotechnology company developing engineered T cell therapies.
Steven Nichtberger, MD, is the Co-founder, Chairman, and CEO of Cabaletta Bio, a clinical-stage biotechnology company developing engineered T cell therapies for B cell-mediated autoimmune diseases. He established Cabaletta Bio in 2017 and oversees the company's discovery and development of targeted cell therapies for autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library